TY - JOUR
T1 - Thyroid function in hidradenitis suppurativa
T2 - a population-based cross-sectional study from Denmark
AU - Miller, I. M.
AU - Vinding, G.
AU - Sørensen, Henrik Ancher
AU - Rytgaard, Helene Charlotte
AU - Mogensen, Ulla Brasch
AU - Ellervik, Cchristina
AU - Jemec, Gregor
N1 - © 2018 British Association of Dermatologists.
PY - 2018/12
Y1 - 2018/12
N2 - Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease. Numerous studies have associated HS with obesity, and recently with metabolic syndrome (MetS). Both obesity and MetS are linked with metabolic changes. Thyroid hormones play a central role in metabolism and exert pleiotropic effects on adipogenesis and the basal metabolism of lipids and glucose. We hypothesized that patients with HS have an altered or dysfunctional metabolism expressed as thyroid function. Aim: To investigate thyroid function in individuals with HS compared with healthy controls (HCs). Methods: We conducted a retrospective comparative cross-sectional study using blood samples and questionnaire-based self-reported information to assess thyroid function. Results: Our study comprised 430 patients in a population-based HS group, and 20 780 HCs. The age/sex-adjusted analysis showed a significantly lower level (P < 0.001) of thyroid-stimulating hormone (TSH) and a significantly higher level (P < 0.0001) of total triiodothyronine (tT3) for the HS compared with the HC group. The age/sex-adjusted analysis also showed a significant association between clinical hyperthyroidism and HS (an OR = 1.91, 95% CI 1.19–3.07; P = 0.02). When this analysis was adjusted further for the potential confounders of body mass index, smoking and oral contraception, the results remained significant. Conclusion: This study suggests that HS is associated with hyperthyroidism. Hyperthyroidism may indicate an altered or dysfunctional metabolism.
AB - Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease. Numerous studies have associated HS with obesity, and recently with metabolic syndrome (MetS). Both obesity and MetS are linked with metabolic changes. Thyroid hormones play a central role in metabolism and exert pleiotropic effects on adipogenesis and the basal metabolism of lipids and glucose. We hypothesized that patients with HS have an altered or dysfunctional metabolism expressed as thyroid function. Aim: To investigate thyroid function in individuals with HS compared with healthy controls (HCs). Methods: We conducted a retrospective comparative cross-sectional study using blood samples and questionnaire-based self-reported information to assess thyroid function. Results: Our study comprised 430 patients in a population-based HS group, and 20 780 HCs. The age/sex-adjusted analysis showed a significantly lower level (P < 0.001) of thyroid-stimulating hormone (TSH) and a significantly higher level (P < 0.0001) of total triiodothyronine (tT3) for the HS compared with the HC group. The age/sex-adjusted analysis also showed a significant association between clinical hyperthyroidism and HS (an OR = 1.91, 95% CI 1.19–3.07; P = 0.02). When this analysis was adjusted further for the potential confounders of body mass index, smoking and oral contraception, the results remained significant. Conclusion: This study suggests that HS is associated with hyperthyroidism. Hyperthyroidism may indicate an altered or dysfunctional metabolism.
U2 - 10.1111/ced.13606
DO - 10.1111/ced.13606
M3 - Journal article
C2 - 29785760
SN - 0307-6938
VL - 43
SP - 899
EP - 905
JO - Transactions of the St. John's Hospital Dermatological Society
JF - Transactions of the St. John's Hospital Dermatological Society
IS - 8
ER -
